Different types of inflammatory response in asthma;Diferentes tipos de respuesta inflamatoria en el asma

Archivos de Bronconeumologia

Volumn 42, Issue SUPPL.1, 2006, Pages 13-19

  Carrillo Díaz, Teresa ^a   Tadeo, Juan Antonio Martínez ^a   Bonny, José Ángel Cumplido ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Asthma; Eosinophils; Epithelial cells; Neutrophils; T lymphocytes

Indexed keywords

ASTHMA; BRONCHUS MUSCLE; CELL STRUCTURE; CELL TYPE; EOSINOPHIL; EPITHELIUM CELL; HUMAN; INFLAMMATION; LYMPHOCYTE; MAST CELL; MONONUCLEAR CELL; NEUTROPHIL; PHENOTYPE; REVIEW; TH2 CELL;

EID: 34547697048     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13097252     Document Type: Article

References (57)

1. Barnes P, Adcock I, Ito K. Histone acetylation and deacetylation: important in inflamatory lung diseases. Eur Respir J. 2005;25:552-63.
2. Holgate ST. Asthma. More than an inflamatory disease. Curr Opin Allergy Clin Immunol. 2002;2:27-9.
3. Quirce S, Pérez E, Carrillo T. Mecanismos patogénicos en el asma. En: Quirce S, Carrillo T, Olaguibel J, editores. Asma (I). Madrid: MRA; 2004. p. 57-74.
4. Larché M, Robison DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 2003;111:450-63.
5. Chatila T. Role of regulatory T cells in human diseases. J Allergy Clin Immunol. 2005;116:949-59.
6. Macaubas C, DeKruyff RH, Umetsu DT. Immunology of the asthmatic response. En: Leung DYM, Sampson HA, Geha RS, et al, editores. Pediatric Allergy. Principles and Practice. New York: Mosby; 2003. p. 337-49.
7. Chanez P. Severe asthma is an epitelial disease. Eur Respir J. 2005;25:945-6.
8. Vignola A, Chiappara G, Siena L, et al. Proliferation and activation of bronchial epitelial cells in corticosteroid-dependent asthma. J Allergy Clin Immunol. 2001;108:738-46.
9. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 2005;172:149-60.
10. Busse WW, Lemanske RF. Asthma. N Engl J Med. 2001;344:350-62.
11. Tattersfield AE, Knox AJ, Britton JR, et al. Asthma. Lancet. 2002;360:1313-22.
12. Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338:1592-600.
13. Walsh GM. Advances in the immunobiology of eosinophils and their role in disease. Crit Rev Clin Lab Sci. 1999;36:453-96.
14. Nagata M, Saito K. The roles of cysteinyl leukotrienes in eosinophilic inflammation of asthmatic airways. Int Arch Allergy Immunol. 2003;131:7-10.
15. Walsh GM. Eosinophil granule protein and their role in disease. Curr Opin Haematol. 2001;8:28-33.
16. Bochner BS. Veredict in the case of therapies versus eosinophils: The jury is still out. J Allergy Clin Immunol. 2004;113:1-7.
17. Lacy P, Weller PF, Moqbel R. A report from the international eosinophil society: eosinophils in a tug of war. J Allergy Clin Immunol. 2001;108:895-900.
18. Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 2003;112:1029-36.
19. Davies DE, Wicks J, Powel RM, et al. Airway remodeling in asthma: new insights. J Allergy Clin Immunol. 2003;111:215-25.
20. Williams TJ. The eosinophil enigma. J Clin Invest. 2004;113:507-9.
21. Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551-60.
22. Payne D, Adcock I, Wilson N, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflamation in children with difficult asthma, after treatment with oral prednisone. Am J Respir Crit Care Med. 2001;164:744-8.
23. Wenzel S, Schwartz L, Langmack E, et al. Evidence that severe asthma can be divided pathologically into two infamatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001-8.
24. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflamation. J Allergy Clin Immunol. 2004;113:101-8.
25. Balzar S, Chu H, Strand M, et al. Relationship of small airway chimase-positive mast cells and luna function in severe asthma. Am J Respir Crit Care Med. 2005;171:43109.
26. Chu H, Balzar S, Wescott J, et al. Expresión and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy. 2002;32:1558-65.
27. Valero Santiago A, Picado C. Asma e idiosincrasia a inflamatorios no esteroideos. En: Quirce S, Carrillo T, Olaguibel J, editores. Asma (II). Madrid: MRA; 2005. p. 143-60.
28. Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643-8.
29. Leckie M, Bryan S, Khan J, et al. Automated quantification of circulating neutrophil and eosinophil activation in asthmatic patients. Thorax. 2000;55:471-7.
30. Norzila M, Fakes K, Henry R, et al. Interleukin-8 and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med. 2000;161:769-74.
31. Loukides S, Bouros D, Papatheodorou G, et al. The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest. 2002;121:338-46.
32. Gibson PG, Simpsom P, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119:1329-36.
33. Green R, Brightling C, Woltmann G, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticoids. Thorax. 2002;57:875-9.
34. Tonnel A, Gosset P, Tillie-Leblond I. Characteristics of the inflammatory response in bronchial lavage fluids from patients with status asthmaticus. Int Arch Allergy Immunol. 2001;124:267-71.
35. Paggiaro P, Bacci E, Paoletti P, et al. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate. Chest. 1990;98:536-42.
36. Hamilton L.M, Torres-Lozano C, Puddicombe S, et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy. 2003;33:233-40.
37. Benayoun L, Druilhe A, Drombet M, et al. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med. 2003;167:1360-8.
38. Caroll N, Carello S, Cooke C, et al. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J. 1996;9:709-15.
39. Carroll NG, Mutavdzic S, James A. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 2002;57:677-82.
40. Wenzel S, Szefler S, Leung D, et al. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoid. Am J Respir Crit Care Med. 1997;156:737-43.
41. Jensen S, Lynch D, Brown K, et al. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol. 2002;57:1078-85.
42. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J Immunol. 1995;154:4719-25.
43. Cundall M, Sun Y, Miranda C, et al. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol. 2003;112:1064-71.
44. Benayoun L, Druilhe A, Dombret M, et al. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med. 2003;167:1360-8.
45. Gagliardo R, Chanez P, Mathieu M, et al. Persistent activation of nuclear-Kappa B signaling pathway in severe incontrolled asthma. Am J Respir Crit Care Med. 2003;168:1190-8.
46. Adcock I, Lane S. Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol. 2003;178:347-55.
47. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003;111:3-22.
48. Matthews J, Ito K, Barnes P, Adcock I. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol. 2004;113:1100-8.
49. Barnes P. Cristal ball. Clin Exp Allergy. 2005;35:843-5.
50. Aaron S, Fergusson D, Dent R, et al. Effect of weight reduction on respiratory function and airway reactivitiy in obese women. Chest. 2004;125:2046-52.
51. Leung D, Hamid Q, Vottero A, et al. Association of glucocorticoid insensitivity with increased expresión of glucocorticoid receptor beta. J Exp Med. 1997;186:1567-74.
52. Ito K, Caramori G, Lim S, et al. Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med. 2002;166:392-6.
53. Cosio B, Mann B, Ito K, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma. Am J Respir Crit Care Med. 2004;170:141-7.
54. Thomson NC, Chaudhuri R, Livingston E. Active cigarette smoking and asthma. Clin Exper Allergy. 2003;33:1471-5.
55. Walter M, Morton J, Kajiwara N, et al. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest. 2002;110:165-75.
56. Holgate S, Lackie P, Howarth P. Activation of epithelial mesenchymal trophic unit in the pathogenesis of asthma. Int Arch Allergy Immunol. 2001;124:253-8.
57. Vachier I, Bonnans C, Chasis C, et al. Severe asthma is associated with a loss of LXA4, an endogenous antiiinflamatory compound. J Allergy Clin Immunol. 2005;115:55-60.